Zivojnović R, Mertens D A, Peperkamp E
Klin Monbl Augenheilkd. 1982 Dec;181(6):444-52.
Indications, results, modified techniques and complications in 280 cases treated with fluid silicon are reported. In about 80% of the cases intravitreal silicon injection under binoscopic control was performed according to the principles described by J. Scott. In the most difficult cases a vitrectomy was carried out and silicon was used only as an internal tamponade. In certain situations the retina itself was treated. The new techniques developed for that purpose are discussed. The follow-up period was between six months and four years. An anatomic success was achieved in more than 70% of the cases. Causes of late complications with the first 100 patients who underwent surgery are discussed. Removal of silicon after a certain period appears a real possibility in spite of initial complications.
报告了280例接受液体硅治疗的适应证、结果、改良技术及并发症。约80%的病例在双目镜控制下根据J. 斯科特描述的原则进行玻璃体内硅注射。在最困难的病例中进行了玻璃体切除术，硅仅用作内部填塞物。在某些情况下，视网膜本身也接受了治疗。讨论了为此目的开发的新技术。随访期为6个月至4年。超过70%的病例获得了解剖学上的成功。讨论了前100例接受手术患者出现晚期并发症的原因。尽管有初始并发症，但在一定时期后取出硅似乎是切实可行的。
